UK SPINE aims to improve health in old age by developing new medicines that target the underlying biology of ageing. We are a partnership between the universities of Oxford, Birmingham, and Dundee, along with EMBL-EBI, The Francis Crick Institute, and the Medicines Discovery Catapult. We identify and validate new drug targets, launch early stage drug discovery projects against these targets, and plan new clinical trial methodology for testing new medicines in older adults.
This event is for you if you would like to learn about how we can help you launch drug discovery projects against targets or pathways linked to ageing.